Table of Contents
ISRN Gastroenterology
Volume 2014 (2014), Article ID 913890, 6 pages
http://dx.doi.org/10.1155/2014/913890
Clinical Study

Parameters Associated with Significant Liver Histological Changes in Patients with Chronic Hepatitis B

Department of Liver Diseases, Taizhou People’s Hospital, Jiangsu 225300, China

Received 20 October 2013; Accepted 12 November 2013; Published 28 January 2014

Academic Editors: W. Vogel and J. Yu

Copyright © 2014 Li Xiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Dienstag, “Drug therapy: hepatitis B virus infection,” The New England Journal of Medicine, vol. 359, no. 14, pp. 1486–1500, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Li, L. Wang, Y. Zhong et al., “Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients,” Journal of Clinical Microbiology, vol. 48, no. 12, pp. 4363–4369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. B. J. McMahon, “Natural history of chronic hepatitis B—clinical implications,” Medscape General Medicine, vol. 10, no. 4, article 91, 2008. View at Google Scholar · View at Scopus
  4. M.-W. Yu, F.-C. Hsu, I.-S. Sheen et al., “Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers,” American Journal of Epidemiology, vol. 145, no. 11, pp. 1039–1047, 1997. View at Google Scholar · View at Scopus
  5. M. Manno, C. Cammà, F. Schepis et al., “Natural history of chronic HBV carriers in Northern Italy: morbidity and mortality after 30 years,” Gastroenterology, vol. 127, no. 3, pp. 756–763, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Martinot-Peignoux, N. Boyer, M. Colombat et al., “Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers,” Journal of Hepatology, vol. 36, no. 4, pp. 543–546, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M.-F. Yuen, “Revisiting the natural history of chronic hepatitis B: impact of new concepts on clinical management,” Journal of Gastroenterology and Hepatology, vol. 22, no. 7, pp. 973–976, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C.-M. Chu and Y.-F. Liaw, “Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus,” American Journal of Gastroenterology, vol. 104, no. 7, pp. 1693–1699, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Mani and D. E. Kleiner, “Liver biopsy findings in chronic hepatitis B,” Hepatology, vol. 49, supplement 5, pp. S61–S71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-F. Liaw, N. Leung, J.-H. Kao et al., “Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update,” Hepatology International, vol. 2, no. 3, pp. 263–283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. European Association for the Study of the Liver, “EASL clinical practice guidelines: management of chronic hepatitis B virus infection,” Journal of Hepatology, vol. 57, no. 1, pp. 167–185, 2012. View at Publisher · View at Google Scholar
  12. A. S. F. Lok and B. J. McMahon, “Chronic hepatitis B: update 2009,” Hepatology, vol. 50, no. 3, pp. 661–662, 2009. View at Publisher · View at Google Scholar
  13. S. L. Friedman, “Preface,” Clinics in Liver Disease, vol. 12, no. 4, pp. 13–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Imbert-Bismut, V. Ratziu, L. Pieroni, F. Charlotte, Y. Benhamou, and T. Poynard, “Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study,” The Lancet, vol. 357, no. 9262, pp. 1069–1075, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Patel, D. R. Nelson, D. C. Rockey et al., “Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C,” Clinical Gastroenterology and Hepatology, vol. 6, no. 2, pp. 242–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Ter Borg, R. A. F. M. Chamuleau, G. N. J. Tytgat et al., “A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals,” Journal of Clinical Pathology, vol. 53, no. 7, pp. 541–548, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Regev, M. Berho, L. J. Jeffers et al., “Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection,” American Journal of Gastroenterology, vol. 97, no. 10, pp. 2614–2618, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Alam, N. Ahmad, G. Mustafa, A. Shrestha, A. K. Alam, and M. Khan, “Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B,” Liver International, vol. 31, no. 6, pp. 826–832, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L.-N. Ma, Z.-M. He, Z.-H. Cao, Y.-H. Zhang, and X.-Y. Chen, “Relationship between liver pathology and clinical characters in HBV carriers,” Zhonghua Gan Zang Bing Za Zhi, vol. 18, no. 6, pp. 433–436, 2010. View at Google Scholar · View at Scopus
  20. C. M. N. Croagh, S. J. Bell, J. Slavin et al., “Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B,” Liver International, vol. 30, no. 8, pp. 1115–1122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Wang, M. Y. Xu, R. D. Zheng et al., “Prediction of significant fibrosis and cirrhosis in hepatitis B e-antigen negative patients with chronic hepatitis B using routine parameters,” Hepatology Research, vol. 43, no. 5, pp. 441–451, 2013. View at Publisher · View at Google Scholar
  22. X. D. Liu, J. L. Wu, J. Liang, T. Zhang, and Q. S. Sheng, “Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients,” World Journal of Gastroenterology, vol. 18, no. 22, pp. 2784–2792, 2012. View at Publisher · View at Google Scholar
  23. J.-B. Nousbaum, J.-F. Cadranel, G. Bonnemaison et al., “Clinical practice guidelines on the use of liver biopsy,” Gastroenterologie Clinique et Biologique, vol. 26, no. 10, pp. 848–878, 2002. View at Google Scholar · View at Scopus
  24. P. Bedossa and T. Poynard, “An algorithm for the grading of activity in chronic hepatitis C,” Hepatology, vol. 24, no. 2, pp. 289–293, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Prati, E. Taioli, A. Zanella et al., “Updated definitions of healthy ranges for serum alanine aminotransferase levels,” Annals of Internal Medicine, vol. 137, no. 1, pp. 1–9, 2002. View at Google Scholar · View at Scopus
  26. M. Kumar, S. K. Sarin, S. Hissar et al., “Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT,” Gastroenterology, vol. 134, no. 5, pp. 1376–1384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Mohamadnejad, G. Montazeri, A. Fazlollahi et al., “Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease,” American Journal of Gastroenterology, vol. 101, no. 11, pp. 2537–2545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Y. Hui, H. L.-Y. Chan, V. W.-S. Wong et al., “Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model,” American Journal of Gastroenterology, vol. 100, no. 3, pp. 616–623, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. W.-K. Seto, C.-L. Lai, P. P. C. Ip et al., “A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B,” PLoS ONE, vol. 7, no. 2, Article ID e32622, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. W. K. Seto, D. K. Wong, J. Fung et al., “High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B,” PLoS ONE, vol. 7, no. 8, Article ID e43087, 2012. View at Publisher · View at Google Scholar
  31. Y. Liu, J. Wang, Y. Huang et al., “Molecular epidemiological study of hepatitis B virus in blood donors from five Chinese blood centers,” Archives of Virology, vol. 157, no. 9, pp. 1699–1707, 2012. View at Publisher · View at Google Scholar
  32. C.-T. Wai, J. K. Greenson, R. J. Fontana et al., “A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C,” Hepatology, vol. 38, no. 2, pp. 518–526, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Y. Park, Y. N. Park, D. Y. Kim et al., “High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels,” Journal of Viral Hepatitis, vol. 15, no. 8, pp. 615–621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Fung, C.-L. Lai, D. But, D. Wong, T.-K. Cheung, and M.-F. Yuen, “Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management,” American Journal of Gastroenterology, vol. 103, no. 6, pp. 1421–1426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. W.-K. Seto, C.-F. Lee, C.-L. Lai et al., “A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B,” PLoS ONE, vol. 6, no. 8, Article ID e23077, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. L. E. Adinolfi, M. G. Giordano, A. Andreana et al., “Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis,” British Journal of Haematology, vol. 113, no. 3, pp. 590–595, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. M.-F. Yuen, Y. Tanaka, I. O.-L. Ng et al., “Hepatic necroinflammation and fibrosis in patients with genotypes Ba and C, core-promoter and precore mutations,” Journal of Viral Hepatitis, vol. 12, no. 5, pp. 513–518, 2005. View at Publisher · View at Google Scholar · View at Scopus